ABSI Latest Headlines

Function-Focused AI and Integrated Labs Set Absci Apart in Next-Gen Drug Discovery

Market Chameleon (Wed, 19-Aug 9:16 AM)

Major Investment from Eli Lilly, BVF Partners, and Others Signals Confidence in Absci’s AI-Driven Drug Discovery

Market Chameleon (Wed, 24-Jun 10:32 AM)

Absci Secures $100 Million Investment to Fuel AI-Driven Biotech Programs—Eli Lilly Leads Strategic Support

Market Chameleon (Wed, 24-Jun 7:05 AM)

Absci’s Generative AI Approach Marks a New Milestone: First AI-Designed Antibody Advances to Clinical Stage

Market Chameleon (Tue, 16-Jun 8:51 AM)

Absci to Join Forces with AI and Compute Leaders—Panel to Spotlight Disruptive Advances in Drug Discovery

Market Chameleon (Mon, 15-Jun 11:56 AM)

ABSci’s Role Spotlighted in Upcoming Jones AI Day Panel Focused on Transforming Drug Discovery with Generative AI

Market Chameleon (Fri, 12-Jun 10:01 AM)

ABSI to Join Forces with Thought Leaders on AI-Driven Drug Discovery at Jones AI Day Panel

Market Chameleon (Fri, 12-Jun 9:13 AM)